Vivo Capital Surplus Fund VIII, L.P.
CIK 0001628048
10% Owner
Filings
4
Latest Apr 3, 2024
Issuers covered
3
Showing
4 of 4
Page 1
Track record
21 of 27 open-market trades scored (78% price coverage) - 6 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 21 | 43% | +1.9% | -9.5% | +28.5% | -15.0% |
| 90 days | 21 | 14% | -15.1% | -15.8% | +3.5% | -32.9% |
| 180 days | 21 | 43% | -12.4% | -17.5% | +13.7% | -39.0% |
| 365 days | 21 | 100% | +48.8% | +40.8% | +63.9% | +34.1% |
Issuers
Companies where Vivo Capital Surplus Fund VIII, L.P. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| BOLT | Bolt Biotherapeutics, Inc. | 2 | Nov 22, 2023 |
| IMPL | Impel Pharmaceuticals Inc | 1 | Dec 19, 2023 |
| TERN | Terns Pharmaceuticals, Inc. | 1 | Apr 3, 2024 |
All filings
4 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|